5 mg
CoA on request
Metabolic Research
Semaglutide
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
$129
View
5 mg - Research material
Metabolic Research
Tirzepatide
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
Research price
$149
5 mg vial - Lyophilized powder
Research Use Only. This material is not for human consumption, injection, clinical use, or veterinary administration. Sold only to qualified researchers and institutions.
RUO policy.
Lot documentation (CoA)
Request a lot-matched Certificate of Analysis for this research material when available. We do not host fabricated PDFs or publish invented purity statistics on product pages.
Specifications
| Size | 5 mg |
|---|---|
| Form | Lyophilized powder |
| Purity / documentation | Lot-specific Certificate of Analysis provided on request when available via the Vial Vault. No instant site-wide purity claims. |
| CAS | 2023788-19-2 |
| Molecular weight | 4813.5 g/mol (reference) |
| Sequence / identity | Dual GIP / GLP-1 receptor agonist peptide (research material) |
| Intended use | In vitro laboratory research only (RUO) |
Research context
Tirzepatide is supplied strictly for research use in metabolic and dual-agonist pathway models. Specs are lot-dependent; request CoA documentation for analytical details. Not intended for human consumption or clinical use.
Research focus areas
Dual agonist research
GIP/GLP-1 pathways
Metabolic model systems
Content is for scientific reference only and does not constitute medical advice or instructions for human use.
Continue your research workflow
Move from catalog specs to literature context, documentation, and lab planning tools. Research use only.
Related research materials
5 mg
CoA on request
Metabolic Research
Retatrutide
Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.
$179
View